<DOC>
	<DOCNO>NCT01653327</DOCNO>
	<brief_summary>- The primary objective determine reduction pain score ketamine mouthwash compare placebo head neck cancer patient refractory mucositis . - The secondary objective describe duration analgesia adverse effect associate ketamine placebo .</brief_summary>
	<brief_title>Analgesic Effects Topical Ketamine Mouthwash Patients Receiving Chemoradiation Radiotherapy Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Subjects diagnose head neck tumor ( histology ) receive ongoing chemoradiation radiation therapy Subjects mucositis pain refractory topical management , define selfreported pain score &gt; 2 24 hour prior enrollment despite use topical agent prescribe Age â‰¥ 18 year Ability understand willingness consent sign consent form Active substance abuse time registration ( alcohol , drug , nonprescription use control substance ) Subjects history allergic reaction ketamine Persistent oral bleeding : &gt; 15 mL ( estimate ) per day Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>mucositis</keyword>
	<keyword>head neck</keyword>
	<keyword>cancer</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>chemoradiation</keyword>
	<keyword>oral</keyword>
	<keyword>pain</keyword>
</DOC>